, Jeong Eun Kang
, Younga Kim
Department of Pediatrics, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea
© 2026 Kosin University College of Medicine.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
No potential conflict of interest relevant to this article was reported.
Funding
This work was supported by a 2-Year Research Grant of Pusan National University.
Author contributions
Conceptualization: YK. Data curation: JEK. Formal analysis: MK. Funding acquisition: YK. Investigation: MK. Methodology: JEK. Project administration: YK. Resources: MK. Software: JEK. Supervision: YK. Validation: YK. Visualization: JEK. Writing-original draft: MK, YK. Writing-review & editing: JEK, YK. All authors have read and approved the final manuscript.
| Variable | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
| Age/sex | 4 mo/female | 5 mo/male | 15 yr/female | 3 yr/male | 13 yr/female |
| Duration of respiratory symptoms (day) | 21 (cough, tachypnea) | 21 (failed ventilator weaning) | 2 (dyspnea) | 14 (gradual ventilator worsening) | 3 (fever, cough, dyspnea) |
| Underlying condition | Maple syrup urine disease | Preterm birth, vitamin D deficiency rickets | Anorexia nervosa, severe malnutrition | Leigh disease with chronic critical illness | Type 2 diabetes mellitus, HHS, multiorgan failure |
| WBC (/µL) | 20,730 | 1,620 | 3,990 | 1,890 | 12,860 |
| ANC (/µL) | 14,096 | 930 | 3,070 | 210 | 10,950 |
| ALC (/µL) | 4,354 | 540 | 490 | 990 | 660 |
| CD4⁺ T cells | NA | NA | NA | 37.0%/366 cells/µLa) | NA |
| Hemoglobin (g/dL) | 7.9 | 9.6 | 8.0 | 8.6 | 8.3 |
| Platelet count (×10³/µL) | 804 | 134 | 100 | 128 | 275 |
| AST (IU/L) | 37 | 43 | 129 | 17 | 37 |
| ALT (IU/L) | 78 | 21 | 126 | 30 | 9 |
| LDH (IU/L) | 1,855 | NA | 361 | 128 | 330 |
| Total protein (g/dL) | 4.1 | 4.0 | 4.7 | 5.0 | 6.0 |
| Albumin (g/dL) | 2.3 | 2.9 | 2.9 | 2.9 | 3.4 |
| CRP (mg/dL) | 3.03 | 2.44 | 3.12 | 4.62 | 2.68 |
| Respiratory specimen for PCR | Tracheal aspirate | Tracheal aspirate | Tracheal aspirate | Tracheal aspirate | Induced sputum |
| CMV PCR (blood) | Negative | Positive | Negative | Negative | NA |
| Respiratory support after treatment (day) | MV, 11 | MV, 11 | MV, 7 | MV, 9 | HFNC, 3 |
Laboratory values represent results obtained at or closest to the time of Pneumocystis jirovecii PCR testing or trimethoprim-sulfamethoxazole (TMP-SMX) initiation.
HHS, hyperosmolar hyperglycemic syndrome; WBC, white blood cell; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NA, not available; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; PCR, polymerase chain reaction; CMV, cytomegalovirus; MV, mechanical ventilation; HFNC, high-flow nasal cannula.
a)CD4⁺ T-cell subset analysis was available only for case 4 and was obtained at the time of TMP-SMX initiation.
| Variable | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
| Age/sex | 4 mo/female | 5 mo/male | 15 yr/female | 3 yr/male | 13 yr/female |
| Duration of respiratory symptoms (day) | 21 (cough, tachypnea) | 21 (failed ventilator weaning) | 2 (dyspnea) | 14 (gradual ventilator worsening) | 3 (fever, cough, dyspnea) |
| Underlying condition | Maple syrup urine disease | Preterm birth, vitamin D deficiency rickets | Anorexia nervosa, severe malnutrition | Leigh disease with chronic critical illness | Type 2 diabetes mellitus, HHS, multiorgan failure |
| WBC (/µL) | 20,730 | 1,620 | 3,990 | 1,890 | 12,860 |
| ANC (/µL) | 14,096 | 930 | 3,070 | 210 | 10,950 |
| ALC (/µL) | 4,354 | 540 | 490 | 990 | 660 |
| CD4⁺ T cells | NA | NA | NA | 37.0%/366 cells/µL |
NA |
| Hemoglobin (g/dL) | 7.9 | 9.6 | 8.0 | 8.6 | 8.3 |
| Platelet count (×10³/µL) | 804 | 134 | 100 | 128 | 275 |
| AST (IU/L) | 37 | 43 | 129 | 17 | 37 |
| ALT (IU/L) | 78 | 21 | 126 | 30 | 9 |
| LDH (IU/L) | 1,855 | NA | 361 | 128 | 330 |
| Total protein (g/dL) | 4.1 | 4.0 | 4.7 | 5.0 | 6.0 |
| Albumin (g/dL) | 2.3 | 2.9 | 2.9 | 2.9 | 3.4 |
| CRP (mg/dL) | 3.03 | 2.44 | 3.12 | 4.62 | 2.68 |
| Respiratory specimen for PCR | Tracheal aspirate | Tracheal aspirate | Tracheal aspirate | Tracheal aspirate | Induced sputum |
| CMV PCR (blood) | Negative | Positive | Negative | Negative | NA |
| Respiratory support after treatment (day) | MV, 11 | MV, 11 | MV, 7 | MV, 9 | HFNC, 3 |
Laboratory values represent results obtained at or closest to the time of HHS, hyperosmolar hyperglycemic syndrome; WBC, white blood cell; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NA, not available; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; PCR, polymerase chain reaction; CMV, cytomegalovirus; MV, mechanical ventilation; HFNC, high-flow nasal cannula. CD4⁺ T-cell subset analysis was available only for case 4 and was obtained at the time of TMP-SMX initiation.